REQUEST A DEMO
Total
USD $0.00
Search more companies

Envee Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Envee Drugs Private Limited Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Envee Drugs Private Limited is an unlisted company, incorporated on 08/12/1998. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ1998PTC035094 and registration number is 035094. The company is a manufacturing company, it is engaged in manufacture of chemicals and chemical products.

Headquarters
N H No. 8 Behaind K Manibhai Godaon Dumral Nadiad In-Gj In 387355
Kheda; Gujarat; Postal Code: 387355

Contact Details: Purchase the Envee Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Envee Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Envee Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Envee Drugs Private Limited report to view the information.
Incorporation Date:
December 08, 1998
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
69.23%
Purchase this report to view the information.
30.74%
Company Performance
Financial values in the chart are available after Envee Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
17.35%
Total operating revenue
16.89%
Operating profit (EBIT)
17.35%
EBITDA
18.19%
Net Profit (Loss) for the Period
27.19%
Total Assets
38.55%
Total Equity
22.03%
Operating Profit Margin (ROS)
0%
Net Profit Margin
0.29%
Return on Equity (ROE)
0.73%
Debt/Equity
-9.63%
Quick Ratio
-0.13%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?